Incannex Healthcare Inc. (Nasdaq: IXHL) announced Tuesday it has secured a financing agreement with Arena Investors, LP for up to $60 million, in a bid to advance the company’s clinical-stage drug candidates. The deal includes up to $10 million in secured convertible notes and a $50 million equity line of …
The recent news that the Drug Enforcement Administration scheduled an administrative hearing for Dec. 2 to “consider differing expert opinions regarding rescheduling of cannabis to schedule III” put many cannabis companies on edge. “The cannabis equity market lurched violently downward on the news as it clearly pushed the issuance of …